Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery Tekijä Xudan Wang, Weiwei Cao, Yan Qiu, Hongchen Ji, Juzheng Yuan, Weikang Wu, Fuyuan Liu, Liangyong Feng, Rui Ding, Xiao Li, Xiao Li, Kaishan Tao

Hae kokoteksti